STOCK PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its partnership with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by more than fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry anal